Correction to: npj Vaccines 10.1038/s41541-022-00475-z, published online 13 May 2022
In the original version of this Article, incorrect numbers were mistakenly inserted in Table 2, introducing a discrepancy with Fig. 2b. The incorrect numbers highlighted in bold in the below table have now been updated in the HTML and PDF version of this Article with the correct numbers. The conclusions of the Article are unchanged.
Table 2.
Adverse events of the intramuscular (IM) and intradermal (ID) boosted ChAdOx1 nCoV-19 (Oxford-AstraZeneca; AZ) in the tested groups.
| AZ IM (4–8 wk) | AZ ID (4–8 wk) | AZ ID (8–12 wk) | |||
|---|---|---|---|---|---|
| Adverse events | Total | Group1 | Group2 | Group3 | P value |
| n = 95 (%) | n = 30 (%) | n = 31 (%) | n = 34 (%) | ||
| Immediate (30 min) | 21 (22.1) | 0 (0) | 7 (22.6) | 14 (41.2) | 0.011 |
| Delayed (7 days) | 71 (74.7) | 20 (66.7) | 25 (80.6) | 26 (76.5) | 0.081 |
| Pain | 43 (45.3) | 11 (36.7) | 16 (51.6) | 16 (47.1) | 0.236 |
| Swelling | 39 (41.1) | 24 (80) | 8 (25.8) | 7 (20.6) | <0.001 |
| Erythema | 35 (36.8) | 27 (90) | 4 (12.9) | 4 (11.8) | <0.001 |
| Nodule | 56 (58.9) | 25 (83.3) | 16 (51.6) | 15 (44.1) | 0.039 |
| Local reactions treatment | 0.405 | ||||
| Grade 1 | 85 (97.7) | 26 (100) | 29 (100) | 30 (93.8) | |
| Grade 2 | 2 (2.3) | 0 (0) | 0 (0) | 2 (6.2) | |
| Systemic reactions | 42 (44.2) | 19 (63.3) | 12 (38.7) | 11 (32.4) | 0.096 |
| Fever | 11 (11.6) | 8 (26.7) | 1 (3.2) | 2 (5.9) | 0.012 |
| Chill | 20 (21.1) | 12 (40) | 5 (16.1) | 3 (8.8) | 0.073 |
| Fatigue | 24 (25.3) | 11 (36.7) | 5 (16.1) | 8 (23.5) | 0.126 |
| Headache | 22 (23.2) | 11 (36.7) | 6 (19.4) | 5 (14.7) | 0.222 |
| Myalgia | 31 (32.6) | 16 (53.3) | 9 (29) | 6 (17.6) | 0.095 |
| Dyspnea | 4 (4.2) | 3 (10) | 1 (3.2) | 0 (0) | 0.354 |
| Joint pain | 4 (4.2) | 3 (10) | 1 (3.2) | 0 (0) | 0.354 |
| Vomiting | 1 (1.1) | 1 (3.3) | 0 (0) | 0 (0) | 0.492 |
| Systemic reactions treatment | 0.174 | ||||
| Grade 1 | 14 (33.3) | 2 (10.5) | 4 (33.3) | 8 (72.7) | |
| Grade 2 | 28 (66.7) | 17 (89.5) | 8 (66.7) | 3 (27.3) |
P value refers comparisons between Group1 and Group2 which were determined using Chi’s square test.